Year-End Report 17/18

September 2017 – August 2018, Diamyd Medical AB (publ), Fiscal year 2017/2018Strong results from DIAGNODE-1Diamyd Medical’s B-share is traded on Nasdaq First North under the ticker DMYD B. Further information is available on https://www.diamyd.com Fourth quarter, June 1– August 31, 2018 ·  Net result amounted to MSEK -11.7 (-6.5). The change compared with the previous year relates to the DIAGNODE-2 trial that started during the financial year. ·  Result per share amounted to SEK -0.2 (-0.1) ·  Cash flow from operating activities amounted to MSEK -9.0 (-9.8) ·  Liquid